{"transactions":[{"id":673541,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2026-08-27T21:12:32.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":280,"price":380,"value":106400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001739452-26-000011","document":"wk-form4_1787865149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000011/wk-form4_1787865149.xml","form_type":"4"}},{"id":726168,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2026-06-25T21:15:07.000Z","date":"2026-06-23","kind":"sale","planned":false,"acquired":false,"shares":1292,"price":276.2592,"value":356926.8864,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.23 to $276.475, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001739452-26-000008","document":"wk-form4_1782422104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000008/wk-form4_1782422104.xml","form_type":"4"}},{"id":731646,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2026-06-18T21:19:48.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":1357,"price":266.7626,"value":361996.8482,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.4658 to $266.8575, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001739452-26-000007","document":"wk-form4_1781817585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000007/wk-form4_1781817585.xml","form_type":"4"}},{"id":737406,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-15T21:55:18.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":229775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"shares","element":"transactionShares","label":"F5","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":229775,"derivative":{"exercise_price":20.81,"expiration_date":"2036-06-10","underlying":"Ordinary Shares","underlying_shares":229775},"source":{"system":"sec-edgar","filing":"0001739452-26-000006","document":"wk-form4_1781560516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000006/wk-form4_1781560516.xml","form_type":"4"}},{"id":737405,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2026-06-15T21:55:18.000Z","date":"2026-06-11","kind":"sale","planned":false,"acquired":false,"shares":626,"price":261.2017,"value":163512.2642,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.19 to $261.29, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001739452-26-000006","document":"wk-form4_1781560516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000006/wk-form4_1781560516.xml","form_type":"4"}},{"id":737404,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Ordinary Shares","published_at":"2026-06-15T21:55:18.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":118625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":1308161,"source":{"system":"sec-edgar","filing":"0001739452-26-000006","document":"wk-form4_1781560516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000006/wk-form4_1781560516.xml","form_type":"4"}},{"id":742669,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2026-06-10T21:23:57.000Z","date":"2026-06-08","kind":"sale","planned":false,"acquired":false,"shares":40,"price":270.55,"value":10822.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001739452-26-000005","document":"wk-form4_1781126634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000005/wk-form4_1781126634.xml","form_type":"4"}},{"id":742668,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2026-06-10T21:23:57.000Z","date":"2026-06-08","kind":"sale","planned":false,"acquired":false,"shares":1444,"price":269.3325,"value":388916.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.88 to $269.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":40,"source":{"system":"sec-edgar","filing":"0001739452-26-000005","document":"wk-form4_1781126634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000005/wk-form4_1781126634.xml","form_type":"4"}},{"id":850239,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Ordinary Shares","published_at":"2026-03-11T00:12:00.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":78624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":1216524,"source":{"system":"sec-edgar","filing":"0001739452-26-000002","document":"wk-form4_1773187917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000002/wk-form4_1773187917.xml","form_type":"4"}},{"id":850238,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Ordinary Shares","published_at":"2026-03-11T00:12:00.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":168922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the\nReporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":1137900,"source":{"system":"sec-edgar","filing":"0001739452-26-000002","document":"wk-form4_1773187917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945226000002/wk-form4_1773187917.xml","form_type":"4"}},{"id":993459,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-19T21:57:42.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":10,"price":382.32,"value":3823.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001739452-25-000006","document":"wk-form4_1763589459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000006/wk-form4_1763589459.xml","form_type":"4"}},{"id":993458,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-19T21:57:42.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":826,"price":381.1891,"value":314862.1966,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.115 to $381.88, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":10,"source":{"system":"sec-edgar","filing":"0001739452-25-000006","document":"wk-form4_1763589459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000006/wk-form4_1763589459.xml","form_type":"4"}},{"id":993457,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-19T21:57:42.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":3155,"price":380.2274,"value":1199617.447,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":836,"source":{"system":"sec-edgar","filing":"0001739452-25-000006","document":"wk-form4_1763589459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000006/wk-form4_1763589459.xml","form_type":"4"}},{"id":998607,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":1769,"price":381.0497,"value":674076.9193,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.00 to $381.50, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998606,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":4240,"price":380.3261,"value":1612582.664,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1769,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998605,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":154,"price":362.0719,"value":55759.0726,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":6009,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998604,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":4846,"price":360.0958,"value":1745024.2468,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.00 to $360.945, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":6163,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998603,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":100,"price":357.4318,"value":35743.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.385 to $357.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":11009,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998602,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":120,"price":355,"value":42600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":11109,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998601,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":251,"price":354.1964,"value":88903.2964,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.59 to $354.585, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":11229,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998600,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":789,"price":352.7773,"value":278341.2897,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.28 to $353.10, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":11480,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998599,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":3240,"price":351.4102,"value":1138569.048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.05 to $351.52, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":12269,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":998598,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-11-14T22:35:30.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":500,"price":350.441,"value":175220.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":15509,"source":{"system":"sec-edgar","filing":"0001739452-25-000005","document":"wk-form4_1763159727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000173945225000005/wk-form4_1763159727.xml","form_type":"4"}},{"id":1064994,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Share Option (Right to Buy)","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":119340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F19","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F22","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events."}],"balance_after":358046,"derivative":{"exercise_price":12.23,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":119340},"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064993,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Share Option (Right to Buy)","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":false,"shares":399828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F19","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":309881,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":399828},"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064992,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Share Option (Right to Buy)","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":false,"shares":352105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F19","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":709709,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":352105},"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064991,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Share Option (Right to Buy)","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":false,"shares":296049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F19","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.  Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":0,"derivative":{"exercise_price":13.42,"expiration_date":"2030-06-16","underlying":"Ordinary Shares","underlying_shares":296049},"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064990,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":600,"price":308.0322,"value":184819.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.99 to $308.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064989,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":4917,"price":307.4285,"value":1511625.9345,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.95 to $307.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064988,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":12232,"price":306.2614,"value":3746189.4448,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.95 to $306.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5517,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064987,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":8522,"price":305.4796,"value":2603297.1512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.95 to $305.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":17749,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064986,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":500,"price":304.1949,"value":152097.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.85 to $304.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":26271,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064985,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":6965,"price":303.3146,"value":2112586.189,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.79 to $303.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":26771,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064984,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":5800,"price":302.0443,"value":1751856.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.52 to $302.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":33736,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064983,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":400,"price":300.8637,"value":120345.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.44 to $301.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":39536,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064982,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":9180,"price":159.03,"value":1459895.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":39936,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064981,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-14","kind":"exercise","planned":true,"acquired":true,"shares":30756,"price":155.68,"value":4788094.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":30756,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064980,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":9617,"price":307.3788,"value":2956061.9196,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.20 to $307.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064979,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":9637,"price":306.7442,"value":2956093.8554,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.19 to $307.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":9617,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064978,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":528,"price":305.5914,"value":161352.2592,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.17 to $306.13, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":19254,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064977,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":7359,"price":304.3738,"value":2239886.7942,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.00 to $304.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":19782,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064976,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":3517,"price":303.544,"value":1067564.248,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.00 to $303.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":27141,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064975,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":5800,"price":302.4472,"value":1754193.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":30658,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064974,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":301.4895,"value":1356702.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":36458,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064973,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":8900,"price":300.3328,"value":2672961.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":40958,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064972,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":true,"shares":27085,"price":155.68,"value":4216592.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":49858,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1064971,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-08-15T20:40:17.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":true,"shares":22773,"price":174.43,"value":3972294.39,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":22773,"source":{"system":"sec-edgar","filing":"0001628280-25-040540","document":"wk-form4_1755290412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000162828025040540/wk-form4_1755290412.xml","form_type":"4"}},{"id":1101496,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-25T21:08:54.000Z","date":"2025-06-23","kind":"sale","planned":false,"acquired":false,"shares":1363,"price":260,"value":354380.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000117","document":"wk-form4_1750885728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000117/wk-form4_1750885728.xml","form_type":"4"}},{"id":1105929,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-18T21:08:07.000Z","date":"2025-06-17","kind":"sale","planned":false,"acquired":false,"shares":630,"price":250.8686,"value":158047.218,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000112","document":"wk-form4_1750280880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000112/wk-form4_1750280880.xml","form_type":"4"}},{"id":1105928,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-18T21:08:07.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":100,"price":266.22,"value":26622.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":630,"source":{"system":"sec-edgar","filing":"0001651308-25-000112","document":"wk-form4_1750280880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000112/wk-form4_1750280880.xml","form_type":"4"}},{"id":1105927,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-18T21:08:07.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":1443,"price":265.4695,"value":383072.4885,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.21 to $266.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":730,"source":{"system":"sec-edgar","filing":"0001651308-25-000112","document":"wk-form4_1750280880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000112/wk-form4_1750280880.xml","form_type":"4"}},{"id":1112860,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-12T21:42:01.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":232245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":232245,"derivative":{"exercise_price":20.26,"expiration_date":"2035-06-09","underlying":"Ordinary Shares","underlying_shares":232245},"source":{"system":"sec-edgar","filing":"0001651308-25-000106","document":"wk-form4_1749764515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000106/wk-form4_1749764515.xml","form_type":"4"}},{"id":1112859,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Ordinary Shares","published_at":"2025-06-12T21:42:01.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":123370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":1274296,"source":{"system":"sec-edgar","filing":"0001651308-25-000106","document":"wk-form4_1749764515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000106/wk-form4_1749764515.xml","form_type":"4"}},{"id":1115972,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-10T20:55:12.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":234,"price":255.7693,"value":59850.0162,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.67 to $255.8887, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000101","document":"wk-form4_1749588905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000101/wk-form4_1749588905.xml","form_type":"4"}},{"id":1115971,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-10T20:55:12.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":400,"price":255.305,"value":102122.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.60 to $255.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":234,"source":{"system":"sec-edgar","filing":"0001651308-25-000101","document":"wk-form4_1749588905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000101/wk-form4_1749588905.xml","form_type":"4"}},{"id":1115970,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-10T20:55:12.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":400,"price":253.4975,"value":101399.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.31 to $253.81, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":634,"source":{"system":"sec-edgar","filing":"0001651308-25-000101","document":"wk-form4_1749588905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000101/wk-form4_1749588905.xml","form_type":"4"}},{"id":1115969,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-10T20:55:12.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":500,"price":251.852,"value":125926.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.585 to $252.14, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1034,"source":{"system":"sec-edgar","filing":"0001651308-25-000101","document":"wk-form4_1749588905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000101/wk-form4_1749588905.xml","form_type":"4"}},{"id":1115968,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"American Depositary Shares","published_at":"2025-06-10T20:55:12.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":400,"price":250.735,"value":100294.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.56 to $251.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1534,"source":{"system":"sec-edgar","filing":"0001651308-25-000101","document":"wk-form4_1749588905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000101/wk-form4_1749588905.xml","form_type":"4"}},{"id":1178708,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"Share Option (Right to Buy)","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":false,"shares":460772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.  Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":296049,"derivative":{"exercise_price":13.42,"expiration_date":"2030-06-16","underlying":"Ordinary Shares","underlying_shares":460772},"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1178707,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"Share Option (Right to Buy)","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":false,"shares":214201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These securities vest over a five-year period as follows: 20% on April 30, 2019, and the remaining in 48 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":0,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":214201},"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1178706,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":5083,"price":283.7932,"value":1442520.8356,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.12 to $284.10, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1178705,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":12221,"price":282.7625,"value":3455640.5125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.03 to $283.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5083,"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1178704,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":6364,"price":281.6736,"value":1792570.7904,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.01 to $282.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":17304,"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1178703,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":28253,"price":280.3114,"value":7919637.9842,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.00 to $280.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":23668,"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1178702,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":true,"shares":35444,"price":174.43,"value":6182496.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":51921,"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1178701,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:04:54.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":true,"shares":16477,"price":119.96,"value":1976580.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":16477,"source":{"system":"sec-edgar","filing":"0001651308-25-000053","document":"wk-form4_1743714287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000053/wk-form4_1743714287.xml","form_type":"4"}},{"id":1198542,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"RMB Shares","published_at":"2025-03-18T20:51:22.000Z","date":"2025-03-14","kind":"sale","planned":false,"acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The term \"RMB Shares\" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the \"STAR Market\") of the Shanghai Stock Exchange (the \"STAR Offering\"), to permitted investors in Renminbi (\"RMB\") within the People's Republic of China (\"PRC\") in accordance with the rules of the STAR Market."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Issuer established an employee participation program (\"RMB Shares Employee Participation Plan\"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924)."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."},{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person disposed of a portion of his economic interest in the RMB Shares Employee Participation Plan and expects to receive net proceeds of approximately RMB7,657,022 (or US$1,057,600 based on an exchange rate of US$1.00 = RMB7.24) for such disposal."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Person disposed of a portion of his economic interest in the RMB Shares Employee Participation Plan and expects to receive net proceeds of approximately RMB7,657,022 (or US$1,057,600 based on an exchange rate of US$1.00 = RMB7.24) for such disposal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Issuer established an employee participation program (\"RMB Shares Employee Participation Plan\"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000051","document":"wk-form4_1742331075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000051/wk-form4_1742331075.xml","form_type":"4"}},{"id":1216827,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"Share Option (Right to Buy)","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":false,"shares":583349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These securities vest over a five-year period as follows: 20% on April 30, 2019, and the remaining in 48 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":214201,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":583349},"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216826,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"Share Option (Right to Buy)","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":false,"shares":91624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These securities vest over a five-year period as follows: 20% on April 30, 2019, and the remaining in 48 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":2,"derivative":{"exercise_price":13.05,"expiration_date":"2028-04-29","underlying":"Ordinary Shares","underlying_shares":91624},"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216825,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":200,"price":263,"value":52600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216824,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":22537,"price":262.5121,"value":5916235.1977,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.00 to $262.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216823,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":11360,"price":261.6093,"value":2971881.648,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.00 to $261.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":22737,"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216822,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":17824,"price":260.3898,"value":4641187.7952,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.00 to $260.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":34097,"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216821,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":true,"shares":44873,"price":119.96,"value":5382965.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":51921,"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216820,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":true,"shares":7048,"price":169.65,"value":1195693.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":7048,"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1216819,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"Ordinary Shares","published_at":"2025-03-08T00:24:01.000Z","date":"2025-03-05","kind":"grant","planned":true,"acquired":true,"shares":103883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the\nReporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":1175210,"source":{"system":"sec-edgar","filing":"0001651308-25-000046","document":"wk-form4_1741393434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000046/wk-form4_1741393434.xml","form_type":"4"}},{"id":1226181,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"RMB Shares","published_at":"2025-03-04T22:17:13.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The term \"RMB Shares\" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the \"STAR Market\") of the Shanghai Stock Exchange (the \"STAR Offering\"), to permitted investors in Renminbi (\"RMB\") within the People's Republic of China (\"PRC\") in accordance with the rules of the STAR Market."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Issuer established an employee participation program (\"RMB Shares Employee Participation Plan\"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924)."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."},{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person disposed of a portion of his economic interest in the RMB Shares Employee Participation Plan and expects to receive net proceeds of approximately RMB8,445,965 (or US$1,161,756 based on an exchange rate of US$1.00 = RMB7.27) for such disposal."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Person disposed of a portion of his economic interest in the RMB Shares Employee Participation Plan and expects to receive net proceeds of approximately RMB8,445,965 (or US$1,161,756 based on an exchange rate of US$1.00 = RMB7.27) for such disposal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Issuer established an employee participation program (\"RMB Shares Employee Participation Plan\"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000038","document":"wk-form4_1741126625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000038/wk-form4_1741126625.xml","form_type":"4"}},{"id":1254927,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"Share Option (Right to Buy)","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-20","kind":"exercise","planned":true,"acquired":false,"shares":276471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These securities vest over a five-year period as follows: 20% on April 30, 2019, and the remaining in 48 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":91626,"derivative":{"exercise_price":13.05,"expiration_date":"2028-04-29","underlying":"Ordinary Shares","underlying_shares":276471},"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1254926,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"Share Option (Right to Buy)","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":false,"shares":398502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These securities vest over a five-year period as follows: 20% on April 30, 2019, and the remaining in 48 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":368097,"derivative":{"exercise_price":13.05,"expiration_date":"2028-04-29","underlying":"Ordinary Shares","underlying_shares":398502},"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1254925,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-20","kind":"sale","planned":true,"acquired":false,"shares":21267,"price":240.0674,"value":5105513.3958,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.50, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1254924,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-20","kind":"exercise","planned":true,"acquired":true,"shares":21267,"price":169.65,"value":3607946.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":21267,"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1254923,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":3159,"price":242.0794,"value":764728.8246,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.00 to $242.28, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1254922,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":7919,"price":241.2626,"value":1910558.5294,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.00 to $241.96, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":3159,"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1254921,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":19576,"price":240.3067,"value":4704243.9592,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":11078,"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1254920,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2025-02-20T23:12:29.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":true,"shares":30654,"price":169.65,"value":5200451.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":30654,"source":{"system":"sec-edgar","filing":"0001651308-25-000018","document":"wk-form4_1740093141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000018/wk-form4_1740093141.xml","form_type":"4"}},{"id":1336724,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"RMB Shares","published_at":"2024-12-11T01:19:56.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The term \"RMB Shares\" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the \"STAR Market\") of the Shanghai Stock Exchange (the \"STAR Offering\"), to permitted investors in Renminbi (\"RMB\") within the People's Republic of China (\"PRC\") in accordance with the rules of the STAR Market."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Issuer established an employee participation program (\"RMB Shares Employee Participation Plan\"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924)."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."},{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person disposed of a portion of his economic interest in the RMB Shares Employee Participation Plan and expects to receive net proceeds of approximately RMB878,900 (or US$120,894 based on an exchange rate of US$1.00 = RMB7.27) for such disposal."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Person disposed of a portion of his economic interest in the RMB Shares Employee Participation Plan and expects to receive net proceeds of approximately RMB878,900 (or US$120,894 based on an exchange rate of US$1.00 = RMB7.27) for such disposal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Issuer established an employee participation program (\"RMB Shares Employee Participation Plan\"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, contributed RMB15 million to the RMB Shares Employee Participation Plan upon the establishment of the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000165","document":"wk-form4_1733879987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000165/wk-form4_1733879987.xml","form_type":"4"}},{"id":1402132,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-09-19T21:25:16.000Z","date":"2024-09-19","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":200.1366,"value":900614.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.85, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000115","document":"wk-form4_1726781110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000115/wk-form4_1726781110.xml","form_type":"4"}},{"id":1402131,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-09-19T21:25:16.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":500,"price":200,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001651308-24-000115","document":"wk-form4_1726781110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000115/wk-form4_1726781110.xml","form_type":"4"}},{"id":1413472,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-09-05T21:41:34.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":274,"price":192.0435,"value":52619.919,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.89 to $192.17, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000112","document":"wk-form4_1725572488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000112/wk-form4_1725572488.xml","form_type":"4"}},{"id":1413471,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-09-05T21:41:34.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":700,"price":191.2049,"value":133843.43,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.86 to $191.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":274,"source":{"system":"sec-edgar","filing":"0001651308-24-000112","document":"wk-form4_1725572488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000112/wk-form4_1725572488.xml","form_type":"4"}},{"id":1413470,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-09-05T21:41:34.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":2275,"price":190.2895,"value":432908.6125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.85 to $190.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":974,"source":{"system":"sec-edgar","filing":"0001651308-24-000112","document":"wk-form4_1725572488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000112/wk-form4_1725572488.xml","form_type":"4"}},{"id":1413469,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-09-05T21:41:34.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":275,"price":188.9736,"value":51967.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.85 to $189.81, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":3249,"source":{"system":"sec-edgar","filing":"0001651308-24-000112","document":"wk-form4_1725572488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000112/wk-form4_1725572488.xml","form_type":"4"}},{"id":1413468,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-09-05T21:41:34.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":2032,"price":188.158,"value":382337.056,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.78 to $188.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":3524,"source":{"system":"sec-edgar","filing":"0001651308-24-000112","document":"wk-form4_1725572488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000112/wk-form4_1725572488.xml","form_type":"4"}},{"id":1468585,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-06-26T21:24:35.000Z","date":"2024-06-24","kind":"sale","planned":false,"acquired":false,"shares":23,"price":161.27,"value":3709.21,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000077","document":"wk-form4_1719437065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000077/wk-form4_1719437065.xml","form_type":"4"}},{"id":1468584,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-06-26T21:24:35.000Z","date":"2024-06-24","kind":"sale","planned":false,"acquired":false,"shares":400,"price":160.3782,"value":64151.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.16 to $161.0328, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":23,"source":{"system":"sec-edgar","filing":"0001651308-24-000077","document":"wk-form4_1719437065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000077/wk-form4_1719437065.xml","form_type":"4"}},{"id":1468583,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-06-26T21:24:35.000Z","date":"2024-06-24","kind":"sale","planned":false,"acquired":false,"shares":1036,"price":159.5297,"value":165272.7692,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.13 to $159.795, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":423,"source":{"system":"sec-edgar","filing":"0001651308-24-000077","document":"wk-form4_1719437065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000077/wk-form4_1719437065.xml","form_type":"4"}},{"id":1472757,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-06-20T21:25:11.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":300,"price":156.8033,"value":47040.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F10","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.61 to $156.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000072","document":"wk-form4_1718918703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000072/wk-form4_1718918703.xml","form_type":"4"}},{"id":1472756,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-06-20T21:25:11.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":300,"price":155.1492,"value":46544.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F10","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.09 to $155.23, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001651308-24-000072","document":"wk-form4_1718918703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000072/wk-form4_1718918703.xml","form_type":"4"}},{"id":1472755,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-06-20T21:25:11.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":906,"price":154.1722,"value":139680.0132,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F10","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.42, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001651308-24-000072","document":"wk-form4_1718918703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000072/wk-form4_1718918703.xml","form_type":"4"}},{"id":1472754,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":18998,"kind":"person","name":"Wu Xiaobin","position":1,"cik":"0001739452","reported_name":"Wu Xiaobin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & GM China"}}],"security":"American Depositary Shares","published_at":"2024-06-20T21:25:11.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":1121,"price":153.6575,"value":172250.0575,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F8","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.47 to $153.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1506,"source":{"system":"sec-edgar","filing":"0001651308-24-000072","document":"wk-form4_1718918703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000072/wk-form4_1718918703.xml","form_type":"4"}}],"next_cursor":"2024-06-20T21:25:11.000000Z,1472754"}